Search
for
Sort by
Research 511–540 of 1000+
- Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases
- Research-based findings on scope of liposome-based cosmeceuticals: an updated review
- Nanocarrier Systems for Transdermal Drug Delivery
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Ex vivo permeation parameters and skin deposition of melatonin-loaded microemulsion for treatment of alopecia
- Analysis of Trend of Studies on Microneedle Treatment System (MTS)
- Nanotechnology-Based Strategies for Hair Regeneration: Mechanistic Insights and Translational Perspectives for Androgenetic Alopecia
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Thiadiazole chitosan conjugates as a novel cosmetic ingredient for rinse-off hair conditioners: design, formulation, characterization and in silico-molecular docking studies
- The Potential Application of Nanocarriers in Delivering Topical Antioxidants
- Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
- Stem Cell Use to Treat Dermatological Disorders
- Mild-temperature photothermal assisted CuSi nanowires for promoting infected wound healing
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Alterations in androgen conjugate levels in women and men with alopecia
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- Postmenopausal virilization after spousal use of topical androgens
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Effect of finasteride on the ovulatory function of normal women
- Efficacy and safety of finasteride?
- Hyperandrogenemia in an ethnically heterogeneous cohort of Midwestern United States diabetic gestations
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Androgen excess is the key element in polycystic ovary syndrome
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent